NorthWest Biotherapeutics Inc (NWBO)

[XMaster2023]

It’s the concept I’m trying to illustrate and discuss. After approval in the states, for all solid tumors, I believe all major hospitals over 500 beds will develop Flaskworks processing capacity. Currently all major hospitals are compounding their own IV chemo mix with Keytruda or other check point inhibitor. This task takes place in a small clean room with a 12” stainless steel exhaust duct and a separate hood. The room might be 12’ x25 ‘ I see the hoods, going away and being replaced with a Flaskworks machine as only certain hospitals will be providing Chemotherapy. Google USP 797 and review the room requirements.

In summary, the large hospitals that have chemo compounding facilities will replace this function because it will outdated, just like your satellite dish. The functional space requirements are very similar.

Imagine.